Crystal structure of Fab fragment of anti-CD22 Epratuzumab
Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| D [auth B] | PK_Tyr_Ser-Thr | e5vkkB1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: PK_Tyr_Ser-Thr | ECOD (v294.1) |
| B [auth L] | PK_Tyr_Ser-Thr | e5vkkL1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: PK_Tyr_Ser-Thr | ECOD (v294.1) |
| C [auth A] | PK_Tyr_Ser-Thr | e5vkkA1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: PK_Tyr_Ser-Thr | ECOD (v294.1) |
| A [auth H] | PK_Tyr_Ser-Thr | e5vkkH1 | A: a/b three-layered sandwiches | X: TIM beta/alpha-barrel | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: PK_Tyr_Ser-Thr | ECOD (v294.1) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| D [auth B] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| B [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| C [auth A] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
| A [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| B [auth L], D [auth B] | Fab Epratuzumab, anti-CD22 | L-KAPPA | Homo sapiens (human) | IGKV4-1*01, IGKJ4*01, IGKJ2*02, IGKJ4*02, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
| A [auth H], C [auth A] | Fab Epratuzumab, anti-CD22 | VH-CH1 | Homo sapiens (human) | IGHV1-3*01, IGHV1-46*01, IGHV1-46*03, IGHV1-69*01, IGHV1-69*11, IGHV1-69*12, IGHV1-69*13, IGHV1-69D*01, IGHV1-69*15, IGHJ6*01, IGHG1*03, IGHG1*08, IGHG1*06 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202611-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B [auth L], D [auth B] | Light Chain | IGKV8 | Kappa | - | SAbDab (2026-03-27) |
| A [auth H], C [auth A] | Heavy Chain | IGHV1 | - | - | SAbDab (2026-03-27) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B [auth L], D [auth B] | Epratuzumab | SIGLEC2/CD22 | Therapeutic SAbDab (2026-03-27) |
| A [auth H], C [auth A] | Epratuzumab | SIGLEC2/CD22 | Therapeutic SAbDab (2026-03-27) |
Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage
| Chains | Polymer | Molecular Function | Biological Process | Cellular Component |
|---|---|---|---|---|
| B [auth L], D [auth B] | Epratuzumab Fab Light Chain | |||
| A [auth H], C [auth A] | Epratuzumab Fab Heavy Chain | - |














